Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 11, November, p. 1561–1566

doi: 10.17219/acem/74682

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The diagnostic potential of glutathione S-transferase (GST) polymorphisms in patients with colorectal cancer

Joanna Waś1,B,C, Monika Karasiewicz2,B,D, Anna Bogacz3,4,A,C, Karolina Dziekan3,B, Małgorzata Górska-Paukszta3,B, Marek Kamiński5,E, Grzegorz Stańko6,B, Adam Kamiński7,E, Marcin Ożarowski8,E, Bogusław Czerny9,F

1 Department of Medical Biology, Institute of Cardiology in Warsaw, Poland

2 Laboratory of International Health, Department of Preventive Medicine, Poznan University of Medical Sciences, Poland

3 Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Poznań, Poland

4 Department of Histocompatibility with Laboratory of Genetic Diagnostics, Regional Blood Center, Poznań, Poland

5 Department of General Surgery and Gastroenterology, Independent Public Clinical Hospital No. 1, Pomeranian Medical University in Szczecin, Poland

6 Department of General and Hand Surgery, Independent Public Clinical Hospital No. 1, Pomeranian Medical University in Szczecin, Poland

7 Department of Orthopedics and Traumatology, Independent Public Clinical Hospital No. 1, Pomeranian Medical University in Szczecin, Poland

8 Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants, Poznań, Poland

9 Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, Poland

Abstract

Background. Colorectal cancer (CRC) is one of the most common cancers in the world. Despite improvements in screening for early diagnosis, CRC is one of the leading causes of cancer deaths.
Objectives. The aim of the study was to determine a potential association between the frequency of GSTM1 and GSTT1 null genotypes and the risk of CRC in the Polish population. Moreover, we analyzed the clinical parameters with the glutathione S-transferase (GST) gene polymorphisms in patients with CRC.
Material and Methods. The study was conducted on 512 Caucasians, including 279 patients (105 women and 174 men) with CRC. DNA from peripheral blood was extracted and the multiplex polymerase chain reaction (PCR) technique was used for glutathione S-transferase theta (GSTT1) and mu (GSTM1) gene deletion genotyping.
Results. We found no statistically significant differences in the frequency of the GST gene polymorphisms in patients with CRC and controls. The prevalence of the GSTM1*0 variant in the test subjects was higher than in controls (45.9% vs 42.9%; p > 0.05). The frequency of the GSTT1*0 variant was also higher in patients with CRC compared to the control population (21.1% vs 18.9%; p > 0.05). In addition, the effect of the GSTM1 and GSTT1 polymorphisms on the incidence of CRC was also analyzed. There was a slight, but not statistically significant, increase of the risk of colon cancer for the GSTM1*0 and GSTT1*0 variants. Moreover, we examined the GST genotype due to the cancer TNM classification and the location of the primary tumor. Statistically significant differences in the distribution of the GSTT1*0 and GSTT1*1 genotypes in both the stage and the location of the primary tumor were observed.
Conclusion. It is suggested that the GSTT1 polymorphism may have an impact on the severity of the tumor and its location.

Key words

colon cancer, gene polymorphism, GSTM1, GSTT1, multiplex polymerase chain reaction

References (29)

  1. Didkowska J, Wojciechowska U, Zatoński W. Cancer in Poland in 2011 [in Polish]. Warszawa: Polish National Cancer Registry, Department of Epidemiology and Cancer Prevention; 2013.
  2. Hezova R, Bienertova-Vasku J, Sachlova M, et al. Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population. Eur J Med Res. 2012;17:17.
  3. Chirila DN, Popp RA, Balacescu O, et al. GST gene variants in synchronous colorectal cancers and synchronous association of colorectal cancers with other cancers. Chirurgia (Bucur). 2013;108:365–371.
  4. Gorukmez O, Yakut T, Gorukmez O, et al. Glutathione S-transferase T1, M1 and P1 genetic polymorphisms and susceptibility to colorectal cancer in Turkey. Asian Pac J Cancer Prev. 2016;17:3855–3859.
  5. Sharma N, Singh A, Singh N, et al. Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population. Cancer Epidemiol. 2015;39:947–955.
  6. Zamora-Ros R, Barupal DK, Rothwell JA, et al. Dietary flavonoid intake and colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. Int J Cancer. 2017;140:1836–1844.
  7. Economopoulos KP, Sergentanis TN. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: A comprehensive meta-analysis. Eur J Cancer. 2010;46:1617–1631.
  8. Beyerle J, Frei E, Stiborova M, et al. Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer. Drug Metab Rev. 2015;47:199–221.
  9. Van Der Logt EM, Bergevoet SM, Roelofs HM, et al. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis. 2004;25:2407–2415.
  10. Arruda VR, Grignolli CE, Goncalves MS, et al. Prevalence of homozygosity for the deleted alleles of glutathione S-transferase mu (GSTMl) and theta (GSTTl) among distinct ethnic groups from Brazil: Relevance to enviromental carcinogenesis. Clin Genet. 1998;54:210–214.
  11. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prevent. 2001;10:1239–1248.
  12. Chenevix-Trench G, Young J, Coggan M, et al. Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility to colon cancer and age of onset. Carcinogenesis. 1995;16:1655–1657.
  13. Ye Z, Parry JM. Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen. 2002;22:385–392.
  14. Ateş NA, Tamer L, Ateş C, et al. Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem Genet. 2005;43:149–163.
  15. Wang J, Jiang J, Zhao Y, et al. Genetic polymorphisms of glutathione S-transferase genes and susceptibility to colorectal cancer: A case-control study in an Indian population. Cancer Epidemiol. 2011;35:66–72.
  16. Martínez C, Martín F, Fernández JM, et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics. 2006;7:711–718.
  17. Gertig DM, Stampfer M, Haiman C, et al. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: A prospective study. Cancer Epidemiol Biomarkers Prev. 1998;7:1001–1005.
  18. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al. Polymorphism of glutathione S-transferase loci GSTM1 and GSTT1 and susceptibility to colorectal cancer in Egypt. Cancer Lett. 1999;142:97–104.
  19. Loktionov A, Watson MA, Gunter M, et al. Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: Interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis. 2001;22:1053–1060.
  20. Zhu Y, Deng C, Zhang Y, et al. The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma. Zhonghua Nei Ke Za Zhi. 2002;41:538–540.
  21. Zhong S, Wyllie AH, Barnes D, et al. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis. 1993;14:1821–1824.
  22. Katoh T, Nagata N, Kuroda Y, et al. Glutathione S-transferase Ml (GSTM1) and Tl (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis. 1996;17: 1855–1859.
  23. Qin X, Zhou Y, Chen Y, et al. Glutathione S-transferase T1 gene polymorphism and colorectal cancer risk: An updated analysis. Clin Res Hepatol Gastroenterol. 2013;37:626–635.
  24. Wan H, Zhou Y, Yang P, et al. Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: A meta-analysis. Cancer Epidemiol. 2010;34:66–72.
  25. Zhang H, Ahmadi A, Arbman G, et al. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. Int J Cancer. 1999;84:135–138.
  26. Butler WJ, Ryan P, Roberts-Thomson IC. Metabolic genotypes and risk for colorectal cancer. J Gastroenterol Hepatol. 2001;16:631–635.
  27. Mondal BC, Paria N, Majumdar S, et al. Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia. Eur J Cancer Prev. 2005;14:281–284.
  28. Davies SM, Robison LL, Buckley JD, et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol. 2001;19:1279–1287.
  29. Wang Y, Yang H, Wang H. The association of GSTT1 deletion polymorphism with lung cancer risk among Chinese population: Evidence based on a cumulative meta-analysis. Oncol Targets Ther. 2015;12: 2875–2882.
© Wroclaw Medical University